Controlling cervical cancer through the implementation of HPV vaccination in Madagascar: providing evidence for implementation strategies – CHIMPS
Situation:
One of the biggest challenges is the health infrastructure in Madagascar: around 40% live more than an hour away from a health centre. Data on HPV is scarce, with initial studies showing high prevalence rates. Vaccination coverage in Madagascar is a major challenge for many diseases, as shown by measles outbreaks or the low COVID-19 vac-cination rate.
Objectives:
To assess the feasibility of the implementation of a nationwide HPV vaccination program
- Cervical cancer screening is available at primary level of care
- Preventive medicine and vaccinology courses are incorporated into the curriculum of medical education
- A tool guide is available to implement vaccine strategies in Madagascar
- 1500 Malagasy women are screened for HPV and cervical cancer
- 300 medical students and health care workers are trai8ned during the course of the project
- Vaccine hesitancy decreases by 10%
- A guidance manual to detail possible strategies for the use of HPV vaccines in Mad-agascar will be produced
CHIMPS is combining humanitarian aid with capacity building and operational research methodologies. The project will adopt a collaborative and participatory approach to ca-pacity strengthening, in order to a) establish a supply chain for HPV vaccines in Madagascar b) build framed education networks on preventive medicine c) reinforce the overall vaccination system in the country. More specifically, this will involve the collab-orative development of e.g. higher education curricula, training-of-trainers’ workshops and seminars, as well as community-based activities. CHIMPS will also contribute to re-inforce the health system at primary level of care.
CHIMPS is a comprehensive project that will have both short- and long-term impacts on the Malagasy population. The introduction of colposcopy at primary level of care al-lows the implementation of integrated programs that could in parallel prevent cervical cancer and identify FGS which is the chronic manifestation of urogenital schistosomia-sis impacting on reproductive health so as increasing the risk for HIV infections and po-tentially cervical cancer onset and progression.
Further information can be found here.